Contraceptive Agents, Female
"Contraceptive Agents, Female" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading.
| Descriptor ID |
D003271
|
| MeSH Number(s) |
D27.505.696.875.360.276 D27.505.954.705.360.276
|
| Concept/Terms |
Contraceptive Agents, Female- Contraceptive Agents, Female
- Agents, Female Contraceptive
- Female Contraceptive Agents
- Contraceptives, Female
- Female Contraceptives
|
Below are MeSH descriptors whose meaning is more general than "Contraceptive Agents, Female".
Below are MeSH descriptors whose meaning is more specific than "Contraceptive Agents, Female".
This graph shows the total number of publications written about "Contraceptive Agents, Female" by people in this website by year, and whether "Contraceptive Agents, Female" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 2 | 0 | 2 |
| 2015 | 0 | 1 | 1 |
| 2019 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Contraceptive Agents, Female" by people in Profiles.
-
Indicators for Monitoring and Evaluation of Community-Based Injectable Contraception: Multisourced Process and New Global Guidance. Glob Health Sci Pract. 2019 09; 7(3):491-497.
-
Prevalence of early discontinuation and associated factors among a retrospective cohort of etonogestrel contraceptive implant users. Eur J Contracept Reprod Health Care. 2019 Dec; 24(6):475-479.
-
Progestin and breast cancer risk: a systematic review. Breast Cancer Res Treat. 2016 Jan; 155(1):3-12.
-
Satisfaction, early removal, and side effects associated with long-acting reversible contraception. Fam Med. 2013 Nov-Dec; 45(10):701-7.
-
The intrauterine device: a good thing revisited. Obstet Gynecol. 2013 May; 121(5):919-920.
-
Predictors of long-acting reversible contraception use among unmarried young adults. Am J Obstet Gynecol. 2012 Jun; 206(6):526.e1-5.
-
Vaginal estrogen supplementation during Depo-Provera initiation: a randomized controlled trial. Contraception. 2010 Sep; 82(3):250-5.
-
Clinical inquiries. What hormonal contraception is most effective for obese women? J Fam Pract. 2007 Jun; 56(6):471-3.
-
Chronic endometritis in DMPA users and Chlamydia trachomatis endometritis. Contraception. 2007 Jul; 76(1):49-52.
-
Endometrial histology of Depomedroxyprogesterone acetate users: a pilot study. Infect Dis Obstet Gynecol. 2006; 2006:69402.